Russian research institute develops new HIV medicine

The Russian Central Research Institute of Epidemiology has developed a new gene therapy medicine for people who have the HIV, head of the federal health and epidemic watchdog Rospotrebnadzor, Anna Popova, said on Wednesday.

“The Central Research Institute of Epidemiology, Rospotrebnadzor created a fundamentally new drug for gene therapy, gene prophylactic treatment and molecular vaccination against HIV.

“A highly active antiviral drug called Dinavir, which will soon be clinically tested, has been created,’’ Popova said on the sidelines of an international conference on HIV and AIDS in Moscow.

The official noted that Russia was facing a number of problems related to treatment of HIV and AIDS, including high prices for treatment and lack of proper medication.

Millions of people have been infected with it causes for the disease were discovered in early 1980s, prompting the development of medicine that would help tackle the deadly virus.

– NAN